<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: We tested the hypothesis that <z:chebi fb="15" ids="28757">fructose</z:chebi>-1,6-bisphosphate, when administered 10 minutes before the end of 2 hours of reversible middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, reduces <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume measured after a 3-day survival period in rats </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: After 1 hour and 50 minutes of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> by the intraluminal suture method, <z:chebi fb="15" ids="28757">fructose</z:chebi>-1,6-bisphosphate, 500 mg/kg in group 1 and 350 mg/kg in group 2 (or an equivalent volume of 1.8% saline as placebo in each group), was given intravenously for a period of 15 minutes to fasted adult Sprague-Dawley rats </plain></SENT>
<SENT sid="2" pm="."><plain>After 2 hours of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, the suture was withdrawn and the rats allowed to survive for 3 days </plain></SENT>
<SENT sid="3" pm="."><plain>The areas of infarction in 10 hematoxylin-eosin-stained coronal sections of the brain were measured and used to calculate <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In group 1, <z:chebi fb="15" ids="28757">fructose</z:chebi>-1,6-bisphosphate decreased total cerebral hemispheric <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by 43% (from 199.6 +/- 11.2 to 114.2 +/- 35.8 mm3, P &lt; .04; mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>Cerebral cortical and subcortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were decreased by 46% (from 137.3 +/- 7.5 to 74.1 +/- 28.6 mm3, P &lt; .04) and 36% (from 62.3 +/- 5.1 to 40.0 +/- 8.3 mm3, P &lt; .04), respectively </plain></SENT>
<SENT sid="6" pm="."><plain>In group 2, <z:chebi fb="15" ids="28757">fructose</z:chebi>-1,6-bisphosphate had no effect on <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in rats that developed mild intraischemic <z:hpo ids='HP_0001945'>hyperthermia</z:hpo>, but in rats kept normothermic during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, <z:chebi fb="15" ids="28757">fructose</z:chebi>-1,6-bisphosphate reduced subcortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volume from 53.7 +/- 8.1 to 18.4 +/- 8.0 mm3 (P &lt; .03) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: <z:chebi fb="15" ids="28757">Fructose</z:chebi>-1,6-bisphosphate improves functional neurological outcome and reduces <z:mpath ids='MPATH_124'>infarct</z:mpath> volume after reversible middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in rats </plain></SENT>
</text></document>